Buy Flubrotizolam (FANAX) 0.5mg For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
What is Flubrotizolam (FANAX) 0.5mg
Flubrotizolam, marketed as FANAX, is a highly potent thienotriazolodiazepine derivative structurally related to classic benzodiazepines. It possesses significant sedative, anxiolytic, muscle relaxant, and hypnotic properties, mediated through high affinity binding to GABA-A receptors in the central nervous system. This compound is primarily researched for its CNS depressant effects and has garnered attention for its strong receptor binding and pharmacological activity. Available in 0.5mg tablets, Flubrotizolam is ideally suited for neuropharmacological study on benzodiazepine-like compounds and their effects.
Technical Information of Flubrotizolam (FANAX)
| Property | Details |
|---|---|
| CAS No | 1246791-67-3 |
| Alternate Names | Flubrotizolam, FANAX, 8-Bromo-6-(2-fluorophenyl)-5H-thieno[2,3-b]thiazolo[5,4-d]pyridazine |
| Chemical Formula | C17H12BrFN4S |
| Molecular Weight | 397.29 g/mol |
| IUPAC Name | 6-(2-Fluorophenyl)-8-bromo-5H-thieno[2,3-b]thiazolo[5,4-d]pyridazine |
| Form | 0.5mg white round tablets |
| Purity | ≥98% (verified by HPLC) |
| Melting Point | 235–245 °C |
| Solubility | Soluble in ethanol, acetone; insoluble in water |
Typical Research Applications of Flubrotizolam (FANAX) 0.5mg
Flubrotizolam is utilized in neuropharmacological research to study the effects of thienotriazolodiazepines on GABAergic neurotransmission. Key applications include evaluation of sedative, anxiolytic, and muscle relaxant activities in preclinical models, as well as comparative pharmacokinetic and toxicological studies. It is also used to explore potential therapeutic effects and risks associated with potent benzodiazepine derivatives.
Safety and Handling Information for Flubrotizolam (FANAX) 0.5mg
Laboratory safety protocols must be strictly followed, including the use of gloves, eye protection, and working within a well-ventilated area or fume hood to minimize exposure risks. Avoid ingestion, inhalation, or skin contact. Dispose of all waste in accordance with institutional safety guidelines. Not intended for human consumption.
Ordering & Shipping Summary for Flubrotizolam (FANAX) 0.5mg
Available exclusively for qualified laboratory research, Flubrotizolam tablets are shipped under secure, regulated conditions to maintain compound stability and integrity. Compliance with local regulations regarding research chemicals is mandatory.
Storage Conditions for Flubrotizolam (FANAX) 0.5mg
Store tablets in airtight containers at controlled room temperature away from moisture, heat, and direct light. Refrigeration is preferred for long-term storage.
Alternatives to Flubrotizolam (FANAX) 0.5mg
Alternatives for comparative research include other benzodiazepine analogues such as phenazepam, bromazepam, and etizolam.
FAQ About Flubrotizolam (FANAX) 0.5mg
Q: What is Flubrotizolam’s primary mode of action?
A: It acts as a potent GABA-A receptor agonist producing CNS depressant effects.
Q: What purity can be expected?
A: Purity is ≥98%, verified through HPLC or equivalent methods.
Q: How should the tablets be stored?
A: In a cool, dry place, preferably refrigerated for long-term stability.
Q: Is Flubrotizolam approved for medical use?
A: No, it is intended only for research purposes.
Call to Action
For reliable, high-purity Flubrotizolam (FANAX) 0.5mg tablets designed for neuroscience research, order from trusted suppliers to ensure safety and experimental accuracy.
Reviews
There are no reviews yet.